6 | Diethylnitrosamine (N-Nitrosodiethylamine)IBA
08/2023
-
09/2011 |
6 | crocinIBA
08/2023
-
01/2015 |
5 | PhytochemicalsIBA
08/2022
-
03/2009 |
5 | safranalIBA
01/2022
-
11/2018 |
4 | Sorafenib (BAY 43-9006)FDA Link
08/2023
-
01/2016 |
4 | AntioxidantsIBA
11/2022
-
12/2012 |
4 | Proteins (Proteins, Gene)FDA Link
01/2022
-
12/2015 |
3 | Cisplatin (Platino)FDA LinkGeneric
09/2023
-
01/2012 |
3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2022
-
01/2017 |
3 | Carbon Tetrachloride (Tetrachloromethane)IBA
11/2020
-
08/2009 |
3 | Streptozocin (Streptozotocin)FDA Link
11/2006
-
06/2004 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2024
-
01/2016 |
2 | Therapeutic UsesIBA
08/2023
-
08/2022 |
2 | DNA (Deoxyribonucleic Acid)IBA
04/2021
-
11/2018 |
2 | Whey ProteinsIBA
01/2021
-
10/2018 |
2 | Blood Glucose (Blood Sugar)IBA
01/2018
-
06/2004 |
2 | Hormones (Hormone)IBA
12/2015
-
06/2007 |
2 | Telomerase (Telomerase Reverse Transcriptase)IBA
12/2015
-
12/2015 |
2 | Polysaccharides (Glycans)IBA
12/2015
-
05/2015 |
2 | Drug CombinationsIBA
12/2015
-
12/2015 |
2 | Technetium Tc 99m Dimercaptosuccinic AcidIBA
01/2015
-
02/2012 |
2 | Succimer (Dimercaptosuccinic Acid)FDA Link
01/2015
-
02/2012 |
2 | Vitamin EFDA LinkGeneric
11/2006
-
06/2004 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
02/2024 |
1 | Scopolamine (Hyoscine)FDA Link
02/2024 |
1 | Cholinergic Antagonists (Anticholinergics)IBA
02/2024 |
1 | Cholinergic Agents (Cholinergics)IBA
02/2024 |
1 | Alanine (L-Alanine)FDA Link
09/2023 |
1 | CarcinogensIBA
09/2023 |
1 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2023 |
1 | CateninsIBA
08/2023 |
1 | Cilostazol (Pletal)FDA LinkGeneric
08/2023 |
1 | SaponinsIBA
07/2023 |
1 | trans-sodium crocetinate (crocetin)IBA
03/2023 |
1 | 3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
01/2023 |
1 | EpitopesIBA
01/2023 |
1 | AndrogensIBA
01/2023 |
1 | QuercetinIBA
11/2022 |
1 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2022 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
01/2022 |
1 | Topoisomerase I InhibitorsIBA
01/2022 |
1 | Syntex adjuvant formulationIBA
01/2022 |
1 | Complex MixturesIBA
06/2021 |
1 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2021 |
1 | Phosphotransferases (Kinase)IBA
04/2021 |
1 | Glutathione Transferase (Glutathione S-Transferase)IBA
02/2021 |
1 | 2-Acetylaminofluorene (2 Acetylaminofluorene)IBA
02/2021 |
1 | Milk Proteins (Milk Protein)IBA
01/2021 |
1 | Peptides (Polypeptides)IBA
01/2021 |
1 | Hematoxylin (Haematoxylon)IBA
11/2020 |
1 | Eosine Yellowish-(YS) (Eosin)IBA
11/2020 |
1 | EnzymesIBA
11/2020 |
1 | Plant Preparations (Preparation, Plant)IBA
11/2020 |
1 | GlycogenIBA
05/2020 |
1 | Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
10/2018 |
1 | ChymotrypsinFDA Link
10/2018 |
1 | Pepsin A (Pepsin)IBA
10/2018 |
1 | CollagenIBA
01/2018 |
1 | BilirubinIBA
01/2018 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
01/2018 |
1 | Insulin (Novolin)FDA Link
01/2018 |
1 | LipidsIBA
01/2018 |
1 | Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2018 |
1 | PPAR alphaIBA
01/2018 |
1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2018 |
1 | Glucagon-Like Peptide 1 (GLP 1)IBA
01/2018 |
1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2018 |